Norway
· Delayed Price · Currency is NOK SoftOx Solutions AS Company Description
SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
Its products include SafeDes+, a hand disinfectant for irritated, compromised, and eczematous skin; and EffectDesH, a surface disinfectant, which has a killing/inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores.
The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigation solutions for acute and chronic wounds to prevent and treat infections, including biofilms; and SoftOx Anti-infectives to treat and remove topical infections in wounded and mucosal tissues, such as biofilms, AMR microbes, viruses, and fungi.
In addition, it is developing antiseptic solutions for pets and livestock; and inhalation solution, a novel and self-administered inhaled drug that is in Phase II clinical trial for early treatment and prevention of influenza-like illnesses.
SoftOx Solutions AS was founded in 2012 and is headquartered in Fornebu, Norway.
| Country | Norway |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Thomas Bjarnsholt |
Contact Details
Address: Martin Linges vei 25 Fornebu, 1364 Norway | |
| Phone | 47 94 85 95 99 |
| Website | soft-ox.com |
Stock Details
| Ticker Symbol | SOFTX |
| Exchange | Oslo Børs |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| ISIN Number | NO0010811961 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Thomas Bjarnsholt | Chief Executive Officer, Chief Medical Officer and Chief Scientific Officer |
| Ingrid Juven | Chief Operating Officer and Chief Financial Officer |
| Elin Lisby Kastberg Jørgensen | International Senior Project Manager |